View Author
fluenza virus vaccination vaccine person titer fluenza virus vaccination fluenza virus vaccine response antibody study fi rst vaccination hi titer pandemic effect group 7 months hi titers signi health care workers 2010. h 1n 2009 difference vaccinated fi nal model ficant 59-adjuvanted strain netherland fi rst fluenza vaccine antibody response monovalent mf 59-adjuvanted fluenza virus vaccines baseline serum 2009. fi rst dose history h 1n viruses immunogenicity 2011. month 60 years antibody titers disease value adult monovalent 137 persons serum sample model trivalent sample infection hospital erasmu interaction health 2009. mf 59-adjuvanted 2009 vaccine vaccine immunol immunity 50 years participant hi antibody response cross-reactive antibodies women signi ficant increase table elisabeth hospital fluenza vaccines downloaded library assay 3 weeks h 1n virus humoral immunity fluenza virus variable
1 Most Recent Publications
|
Immunogenicity, boostability, and sustainability of the immune response after vaccination against influenza A virus (H1N1) 2009 in a healthy population
(Article)
Huijskens, E. Rossen, J. Mulder, P. Beek, R. van Vugt, H. van Verbakel, J. Rimmelzwaan, G.F. Koopmans, M. Peeters, M. |
2011-09-01
|